Zolmitriptan

CAS 139264-17-8 16 current records 3 historicalSmall Molecule

Who holds supplier records for Zolmitriptan? 16 organisations hold a current record for Zolmitriptan: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), Spain (1), Taiwan (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Zolmitriptan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zolmitriptan

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    13 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Zolmitriptan. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Zolmitriptan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Zolmitriptan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2018-255 - Rev 04
Zolmitriptan
Jul 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2026-056 - Rev 00
Zolmitriptan, Micronised and Non-micronised
May 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2020-422 - Rev 04
Zolmitriptan
May 2026—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Zolmitriptan are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Overview

Zolmitriptan is a selective serotonin receptor agonist of the triptan class used to treat migraine headaches. It works by narrowing the blood vessels around the brain and reducing substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, and other migraine symptoms.

Chemical identity

IUPAC name
(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
Canonical SMILES
CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
InChIKey
ULSDMUVEXKOYBU-ZDUSSCGKSA-N
Synonyms
Zomig API, 311-c-90, 311c90, cvt-427, nsc-760383, zomig

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of action
Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists

Therapeutic areas

Migraine TreatmentNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Zolmitriptan?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Zolmitriptan: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), ALIVUS LIFE SCIENCES LTD (India), Dr. Reddy's Laboratories Ltd. (India), Emcure Pharmaceuticals Limited (India), Hetero Drugs Limited (India) and INKE SA (Spain), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Zolmitriptan Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 25503), APITORIA PHARMA PRIVATE LTD (DMF 27502), MATRIX PHARMACORP PRIVATE LTD (DMF 20639), ALIVUS LIFE SCIENCES LTD (DMF 22237), Dr. Reddy's Laboratories Ltd. (DMF 25734, 20194), Emcure Pharmaceuticals Limited (DMF 26105), Hetero Drugs Limited (DMF 25297) and INKE SA (DMF 24649) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Zolmitriptan records mean?

3 organisations have only inactive Type II DMFs for Zolmitriptan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Zolmitriptan have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Zolmitriptan on the EDQM register, including ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Zolmitriptan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Zolmitriptan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.